EC Neurology

Case Report Volume 17 Issue 5 - 2025

Rapidly Progressive Dementia and Hyperkinetic Syndrome, Report of a Case of Creutzfeldt-Jakob Disease, at the General Hospital of Mexico

Nancy Patricia Moreno-Aldama*

Neurology, with a Specialized on Degenerative Diseases and Movement Disorders, Hospital General de México Dr. Eduardo Liceaga, Mexico City, Mexico

*Corresponding Author: Nancy Patricia Moreno-Aldama, Neurology, with a Specialized on Degenerative Diseases and Movement Disorders, Hospital General de México Dr. Eduardo Liceaga, Mexico City, Mexico.
Received: April 10, 2025; Published: May 15, 2025



Creutzfeldt-Jakob disease is a fatal neuroselective and neurodegenerative condition, rare in daily clinical practice, a rare brain disorder that causes muscle spasms and dementia; establishing the clinical diagnosis represents a challenge for the treating physician. It should be clinically suspected of rapidly progressive dementia, concomitant with myoclonus, cerebellar involvement, visual disturbances, or psychiatric condition. We present the case of a 59-year-old patient who presented to the neurology service with cognitive impairment plus movement disorder, with a fatal outcome.

 Keywords: Creutzfeldt-Jakob Disease; Prions; Rapidly Progressive Dementia; Myoclonus; Chorea

  1. Cartier-Rovirosa L. “Prion disease, human spongiform encephalopathy and Creutzfeldt-Jakob disease”. Revista Médica de Chile 9 (2019): 1176-1183.
  2. Legua-Koc S., et al. “Creutzfeldt-Jakob disease: 5-year experience in a tertiary hospital in Chile”. Revista Médica de Chile9 (2021): 1285-1291.
  3. Pitarch Fabregat J., et al. “Visual disturbance as an initial manifestation of Creutzfeldt-Jakob disease”. Medicina Clínica 11 (2021): e335-e336.
  4. Gómez Roldós A., et al. “Refractory status epilepticus in genetic Creutzfeldt-Jakob disease with E200K mutation”. Neurología (English Edition) 9 (2020): 712-714.
  5. Mantilla Flórez YF., et al. “Creutzfeldt's disease Jakob. Presentation of a case and review of the literature”. Revolution Medicines 2 (2019): 103-111.
  6. Ramírez M., et al. “Challenges in the diagnosis of Creutzfeldt-Jakob disease: a clinical case”. Revista Médica de Chile 6 (2016): 806-811.
  7. García-Ortega YE., et al. “Creutzfeldt-Jakob disease”. Medicina Interna de México 5 (2019): 795-801.
  8. Garnés Sánchez CM., et al. “Electroencephalographic and polysomnographic findings in a patient with familial Creutzfeldt-Jakob disease”. Neurology9 (2018): 625-628.
  9. Briones-Torres CA., et al. “Study of 14-3-3 and Tau proteins as biomarkers in patients with neurodegenerative diseases of undetermined origin. Experience in the Clinical Pathology Laboratory of Médica Sur”. Revista de Investigación Médica Sur 3 (2014): 116-119.
  10. Mercado-Flores M., et al. “Magnetic resonance imaging findings in rapidly progressive dementia, probable Creutzfeldt-Jakob prion disease sporadic form”. Annals of Radiology Mexico3 (2015): 292-298.
  11. Pérez-Pérez J., et al. “Atypical presentation in brain resonance imaging of Creutzfeldt-Jakob disease: a case report”. Neurología Argentina 2 (2023):98-103.
  12. González-Ramos S., et al. “Clinical-epidemiological characterization of Creutzfeldt-Jakob disease in a hospital center”. Revista Científica Estudiantil HolCien 3 (2023): 210-215.
  13. Rodríguez-Melgarejo P., et al. “Experience with Creutzfeldt-Jakob disease from a single reference center in Mexico: Analysis of a case series”. Gaceta Médica de México 6 (2022): 321-326.
  14. Tian H., et al. “Recent advancements in the diagnosis of Creutzfeldt-Jakob disease: a review”. Journal of the Neurological Sciences 420 (2021): 117242.
  15. Lee JM., et al. “Clinical and imaging findings in a patient with Creutzfeldt-Jakob disease and temporal lobe involvement”. Clinical Neurology and Neurosurgery 206 (2021): 106711.

Nancy Patricia Moreno-Aldama. “Rapidly Progressive Dementia and Hyperkinetic Syndrome, Report of a Case of Creutzfeldt-Jakob Disease, at the General Hospital of Mexico”. EC Neurology  17.5 (2025): 01-07.